Format

Send to

Choose Destination
See comment in PubMed Commons below
J Vasc Interv Radiol. 2013 Feb;24(2):241-54. doi: 10.1016/j.jvir.2012.10.017. Epub 2013 Jan 28.

Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies.

Author information

1
Department of Radiology, Division of Interventional Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, 525 East 68th Street, P-518, New York, NY 10065, USA.

Abstract

Portal vein embolization (PVE) is an established therapy used to redirect portal blood flow away from the tumor-bearing liver to the anticipated future liver remnant (FLR) and usually results in FLR hypertrophy. PVE is indicated when the FLR is considered too small before surgery to support essential function after surgery. When appropriately applied, PVE reduces postoperative morbidity and increases the number of patients eligible for curative hepatic resection. PVE also has been combined with other therapies to improve patient outcomes. This article assesses more recent outcomes data regarding PVE, reviews the existing controversies, and reports on novel strategies currently being investigated.

PMID:
23369559
DOI:
10.1016/j.jvir.2012.10.017
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center